This study aims to determine if early treatment with Carbidopa/Levodopa and Naproxen in
individuals with sub-acute back pain (SBP) is associated with changes in blocking transition
to chronic back pain (CBP).
Phase:
Phase 4
Details
Lead Sponsor:
Northwestern University
Collaborators:
National Institute of Dental and Craniofacial Research (NIDCR) National Institutes of Health (NIH)
Treatments:
Carbidopa Carbidopa, levodopa drug combination Levodopa Naproxen